Gene hunt: could DNA testing shorten the wait for answers in infant epilepsy?
NCT ID NCT06701084
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find new genetic causes of epilepsy in infants whose seizures start before 12 months of age. Researchers will analyze the DNA of 600 babies to see if a genetic diagnosis can be made and how that affects medical care and family well-being. The goal is to shorten the time to diagnosis and improve understanding of these early-life epilepsies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Genomic sequencing
- What this could lead to
- If successful, this could improve early genetic diagnosis for infant epilepsy, guiding treatment and family counseling.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly change outcomes, and genetic findings may not always be actionable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFANTILE EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States